FDA slows down on drug reviews, approvals amid Trump admin chaos

Amid the chaos of the Trump administration’s haphazard job cuts and a mass exodus of leadership, the Food and Drug ...

Exclusive-FDA nicotine pouch pilot to ease manufacturers' research burden, transcript shows

The U.S. Food and Drug Administration will ease requirements on nicotine pouch manufacturers under a new pilot program, ...
Agence France-Presse

Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product

Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific ...

FDA unveils drugs to receive expedited review in support of 'national priorities'

The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at ...

Marlboro maker Altria takes $2.6 bln hit as Juul valuation crumbles

Altria Group Inc on Friday took a third-quarter hit of $2.6 billion to its investment in Juul Labs Inc, further diminishing the value of its initial $12.8 billion stake in the e-cigarette maker that ...
STAT

FDA announces first nine recipients of priority drug review vouchers

FDA announced the first nine recipients of priority review vouchers, which offers expedited drug review to products aligned ...
STAT

Biotech leaders say uncertainty at FDA threatens drug development

The FDA's rejections of Replimune and Capricor therapies show how instability threatens biotech innovation, CEOs say.
Compliance Week

Navigating HHS and FDA’s overhaul of the food and beverage industry

Under the Trump administration, the Department of Health and Human Services and the Food and Drug Administration have been ...